Abstract

A CLINICAL VALIDATION OF SAFETY AND EFFECTIVENESS OF DE-STRESS & FOCUS TABLET

Dr. Kriti Soni*, Dr. Sachin Mulik and Dr. Gayatri Ganu

.

Abstract

Background: Neuropsychiatric conditions like Attention Deficit Hyperactivity Disorder (ADHD) and stress disorders significantly impact global population functioning. With worldwide ADHD prevalence ranging from 5.29% to 7.1%, there is a critical need for alternative therapeutic interventions. This clinical trial investigated the safety and efficacy of a novel nutraceutical formulation in managing stress and improving cognitive performance. Materials and Methods: A 30-day open-label, non-randomized clinical trial was conducted with 30 participants (10 males, 20 females). Participants received one De- Stress & Focus tablet daily. Efficacy assessments included haematological parameters, vital signs, and self-reported measures of alertness, memory, and energy levels using a 4-point Likert scale. Safety was evaluated through adverse event monitoring and biochemical investigations. Results: Significant improvements were observed in participants' cognitive functions. At baseline, 27 subjects reported worsened alertness and memory, which improved to 100% satisfactory levels post-intervention. Statistically significant reductions were noted in systolic blood pressure (p=0.035) and body temperature (p

Keywords: De-stress, Focus, Alpinia galanga, Ashwagandha, Cognitive function, Stress reduction.